Beyond Genomix SA
Beyond Genomix is a clinical-stage medtech company specializing in advanced genomics and aging biomarker analysis technologies. Their proprietary platform integrates multi-omics data with AI-powered analytics to provide detailed insights into age-associated diseases, focusing on telomere length, senescence biomarkers, and genetic variants. The company has developed a world-leading, sensitive, and automated qFISH-based telomere analysis technology that enables single-cell resolution, offering superior diagnostic capabilities for age-related diseases and reproductive health issues such as idiopathic infertility. Beyond Genomix leverages its technology and proprietary infertility database to deliver personalized treatment recommendations, optimizing patient outcomes and advancing drug discovery. The company collaborates with leading research institutions and aims to transform medicine by reshaping diagnostics and therapeutics for aging and reproductive health.
Beyond Genomix SA
Beyond Genomix is a clinical-stage medtech company specializing in advanced genomics and aging biomarker analysis technologies. Their proprietary platform integrates multi-omics data with AI-powered analytics to provide detailed insights into age-associated diseases, focusing on telomere length, senescence biomarkers, and genetic variants. The company has developed a world-leading, sensitive, and automated qFISH-based telomere analysis technology that enables single-cell resolution, offering superior diagnostic capabilities for age-related diseases and reproductive health issues such as idiopathic infertility. Beyond Genomix leverages its technology and proprietary infertility database to deliver personalized treatment recommendations, optimizing patient outcomes and advancing drug discovery. The company collaborates with leading research institutions and aims to transform medicine by reshaping diagnostics and therapeutics for aging and reproductive health.